Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07413913
PHASE1

A Study in Healthy People or Otherwise Healthy With Overweight or Obesity to Compare 2 Formulations of Survodutide Given in Different Ways, Either as a Pre-filled Syringe or a Pen-like Injector

Sponsor: Boehringer Ingelheim

View on ClinicalTrials.gov

Summary

The goal of this study is to find out whether different formulations of survodutide given by different delivery methods is taken up in the body in a similar way. Participants visit the study site regularly. During study visits, the doctors collect information about participants' health. To assess the study endpoints, participants regularly have blood samples taken.

Official title: Bioequivalence of Survodutide (BI 456906) When Administered Via Pre-filled Syringe (Formulation A) and Pre Filled Pen (Formulation B2) in Male and Female Trial Participants Who Are Healthy or Otherwise Healthy With Overweight/Obesity (an Open-label, Randomised, Single-dose, Two-period, Two-sequence Crossover Trial)

Key Details

Gender

All

Age Range

18 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

56

Start Date

2026-03-03

Completion Date

2026-06-08

Last Updated

2026-03-05

Healthy Volunteers

Yes

Conditions

Interventions

DRUG

Survodutide formulation A

Pre-filled syringe

COMBINATION_PRODUCT

Survodutide formulation B2

Pre-filled pen

Locations (1)

Humanpharmakologisches Zentrum Biberach

Biberach, Germany